Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells

Journal of Experimental Medicine

Volumn 199, Issue 6, 2004, Pages 879-884

  Street, Shayna E A ^a   Hayakawa, Yoshihiro ^a   Zhan, Yifan ^b   Lew, Andrew M ^b   MacGregor, Duncan ^c   Jamieson, Amanda M ^d   Diefenbach, Andreas ^e   Yagita, Hideo ^f   Godfrey, Dale I ^g   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Effector; Immunosurveillance; NK cell; Perforin; Tumor

Indexed keywords

BETA 2 MICROGLOBULIN; CD16 ANTIGEN; CD1D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOSURVEILLANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR REJECTION;

ANIMALS; BETA 2-MICROGLOBULIN; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PERITONEUM; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES;

EID: 12144290645     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031981     Document Type: Article

References (34)

1. van den Broek, M.F., D. Kagi, R.M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514-3516.
2. Smyth, M.J., J.M. Kelly, A.G. Baxter, H. Korner, and J.D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611-1619.
3. Smyth, M.J., K.Y. Thia, S.E. Street, E. Cretney, J.A. Trapani, M. Taniguchi, T. Kawano, S.B. Pelikan, N.Y. Crowe, and D.I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661-668.
4. Smyth, M.J., M. Taniguchi, and S.E. Street. 2000. The antitumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 165:2665-2670.
5. Smyth, M.J., K.Y. Thia, S.E. Street, D. MacGregor, D.I. Godfrey, and J.A. Trapani. 2000. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192:755-760.
6. Smyth, M.J., K.Y. Thia, E. Cretney, J.M. Kelly, M.B. Snook, C.A. Forbes, and A.A. Scalzo. 1999. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162:6658-6662.
7. Street, S.E., E. Cretney, and M.J. Smyth. 2001. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 97:192-197.
8. Cretney, E., K. Takeda, H. Yagita, M. Glaccum, J.J. Peschon, and M.J. Smyth. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168:1356-1361.
9. Kaplan, D.H., V. Shankaran, A.S. Dighe, E. Stockert, M. Aguet, L.J. Old, and R.D. Schreiber. 1998. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 95:7556-7561.
10. Street, S.E., J.A. Trapani, D. MacGregor, and M.J. Smyth. 2002. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 196:129-134.
11. Enzler, T., S. Gillessen, J.P. Manis, D. Ferguson, J. Fleming, F.W. Alt, M. Mihm, and G. Dranoff. 2003. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J. Exp. Med. 197:1213-1219.
12. Shankaran, V., H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, and R.D. Schreiber. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410:1107-1111.
13. Smyth, M.J., J.R. Ortaldo, Y. Shinkai, H. Yagita, M. Nakata, K. Okumura, and H.A. Young. 1990. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J. Exp. Med. 171:1269-1281.
14. Nakata, M., M.J. Smyth, Y. Norihisa, A. Kawasaki, Y. Shinkai, K. Okumura, and H. Yagita. 1990. Constitutive expression of pore-forming protein in peripheral blood gamma/ delta T cells: implication for their cytotoxic role in vivo. J. Exp. Med. 172:1877-1880.
15. Natarajan, K., N. Dimasi, J. Wang, R.A. Mariuzza, and D.H. Margulies. 2002. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20:853-885.
16. Cerwenka, A., and L.L. Lanier. 2001. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 181:158-169.
17. Smyth, M.J., N.Y. Crowe, and D.I. Godfrey. 2001. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13:459-463.
18. Smyth, M.J., D.I. Godfrey, and J.A. Trapani. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2:293-299.
19. Girardi, M., D.E. Oppenheim, C.R. Steele, J.M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R.E. Tigelaar, and A.C. Hayday. 2001. Regulation of cutaneous malignancy by gammadelta T cells. Science. 294:605-609.
20. Zijlstra, M., M. Bix, N.E. Simister, J.M. Loring, D.H. Raulet, and R. Jaenisch. 1990. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 344:742-746.
21. Smyth, M.J., and M.B. Snook. 1999. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice. Cell. Immunol. 196:51-59.
22. Rajan, A.J., Y.L. Gao, C.S. Raine, and C.F. Brosnan. 1996. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 157:941-949.
23. Kaufmann, S.H., C. Blum, and S. Yamamoto. 1993. Crosstalk between alpha/beta T cells and gamma/delta T cells in vivo: activation of alpha/beta T-cell responses after gamma/delta T-cell modulation with the monoclonal antibody GL3. Proc. Natl. Acad. Sci. USA. 90:9620-9624.
24. Liao, N.S., M. Bix, M. Ziljstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 253:199-202.
25. Shultz, L.D., P.A. Schweitzer, S.W. Christianson, B. Gott, I.B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T.V. Rajan, D.L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180-191.
26. Crowe, N.Y., A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M.J. Smyth, and D.I. Godfrey. 2003. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171:4020-4027.
27. Yeung, M.M., S. Melgar, V. Baranov, A. Oberg, A. Danielsson, S. Hammarstrom, and M.L. Hammarstrom. 2000. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut. 47:215-227.
28. Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:165-171.
29. Erianne, G.S., J. Wajchman, R. Yauch, V.K. Tsiagbe, B.S. Kim, and N.M. Ponzio. 2000. B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth. Leuk. Res. 24:705-718.
30. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149-1154.
31. + T cells to different stages of chemically induced skin cancer. J. Exp. Med. 198:747-755.
32. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA. 96:6879-6884.
33. Gao, Y., W. Yang, M. Pan, E. Scully, M. Girardi, L.H. Augenlicht, J. Craft, and Z. Yin. 2003. γδT cells provide an early source of interferon γ in tumor immunity. J. Exp. Med. 198:433-442.
34. Cerwenka, A., J.L. Baron, and L.L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA. 98:11521-11526.